Immune regulation by regulatory T cells: Implications for transplantation

Transplant Immunology

Volumn 11, Issue 3-4, 2003, Pages 267-276

  Jonuleit, Helmut ^a   Adema, Gosse ^b   Schmitt, Edgar ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dendritic cells; Immunoregulation; Regulatory T cells; Suppression; Tolerance

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALLOANTIGEN; ANTIBIOTIC AGENT; AUTOANTIGEN; CORTICOSTEROID; CYTOKINE; DIHYDROXYCOLECALCIFEROL; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTEGRIN; INTERLEUKIN 10; MONOCLONAL ANTIBODY; OKT 4; PROSTAGLANDIN; PROTEIN; TOLEROGEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ALLERGY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CELL SUBPOPULATION; CLINICAL TRIAL; DENDRITIC CELL; DISEASE SEVERITY; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATORY DISEASE; INHIBITION KINETICS; LYMPHOCYTE TRANSFUSION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; THYMUS; TUMOR;

EID: 0141853311     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00057-1     Document Type: Article

References (65)

1. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998:19(9):395-404.
2. Sprent J, Kishimoto H. The thymus and negative selection. Immunol Rev 2002;185:126-135.
3. Seddon B, Mason D. The third function of the thymus. Immunol Today 2000;21(2):95-99.
4. Gerson RK. A disquisition on suppressor T cells. Transplant Rev 1975;26:170-185.
5. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155(3):1151-1164.
6. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193(11):1285-1294.
7. Dieckmann D, Plotter H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001;193(11):1303-1310.
8. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, et al. Human CD4(+)CD25(+) cells: A naturally occurring population of regulatory T cells. Blood 2001;98(9):2736-2744.
9. Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 1999;189(5):877-882.
10. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188(2):287-296.
11. Papiernik M, DE Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4 T cells: Expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998;10(4):371-378.
12. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160(3):1212-1218.
13. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190(7):995-1004.
14. + T cells. J Exp Med 1996;183(6):2669-2674.
15. Sundstedt A, O'Neill EJ, Nicolson KS, Wraith DC. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 2003;170(3):1240-1248.
16. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: Human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002;196(2),:255-260.
17. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induced interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002;196(2):247-253.
18. Berg EL, Goldstein LA, Jutila MA, Nakache M, Picker LJ, Streeter PR, et al. Homing receptors and vascular addressins: Cell adhesion molecules that direct lymphocyte traffic. Immunol Rev 1989;108:5-18.
19. Berlin C, Bargatze RF, Campbell JJ, Von Andrian UH, Szabo MC, Hasslen SR, et al. Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80(3):413-422.
20. Wells H. Studies on the chemistry of anaphylaxis III. Experiments with isolated proteins, especially those of the hen's egg. J Infect Dis 1911;9:147-150.
21. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001;182:207-214.
22. Thurau SR, Wildner G. Oral tolerance for treating uveitis - New hope for an old immunological mechanism. Prog Retinal Eye Res 2002;21(6):577-589.
23. Im SH, Barchan D, Souroujon MC, Fuchs S. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis. J Immunol 2000;165(7):3599-3605.
24. Garcia G, Komagata Y, Slavin AJ, Maron R, Weiner HL. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. J Autoimmun 1999;13(3):315-324.
25. Haque MA, Yoshino S, Inada S, Nomaguchi H, Tokunaga O, Kohashi O. Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein. Eur J Immunol 1996;26(11):2650-2656.
26. Homann D, Dyrberg T, Petersen J, Oldstone MB, Von Herrath MG. Insulin in oral immune 'tolerance': A one-amino acid change in the B chain makes the difference. J Immunol 1999;163(4):1833-1838.
27. Zavazava N, Fandrich F, Zhu X, Freese A, Behrens D, Yoo-Ott KA. Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination. J Leukocyte Biol 2000;67(6):793-800.
28. Weiner HL, Friedman A, Miller A, Khoury SH, Al Sabbagh A, Santos L, et al. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-837.
29. Shiloh MU, MacMicking JD, Nicholson S, Brause JE, Potter S, Marino M, et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 1999;10(1):29-38.
30. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5(11):1461-1471.
31. + T cells. J Exp Med 1993;178(1):237-244.
32. Singh B, Read S, Asseman C, Malstrom V, Mottet C, Stephens LA, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200.
33. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192(2):295-302.
34. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75(2):263-274.
35. Del Prete G. Human Th1 and Th2 lymphocytes: Their role in the pathophysiology of atopy. Allergy 1992;47(5):450-455.
36. Russo M, Nahori MA, Lefort J, Gomes E, De Castro KA, Rodriquez D, et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol 2001;24(5):518-526.
37. Katagiri K, Zhang-Hoover J, Mo JS, Stein-Streinlein J, Streilein JW. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J Immunol 2002;169(1):84-89.
38. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe TT, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8(9):1024-1032.
39. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002;420(6915):502-507.
40. Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: Primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990;20(12):2747-2755.
41. Koenen HJ, Joosten I. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness. Blood 2000;95(10):3153-3161.
42. Isobe M, Suzuki J, Yamazaki S, Horie S, Okubo Y, Sekiguchi M. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. J Heart Lung Transplant 1997;16(11):1149-1156.
43. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999;5(6):686-693.
44. + regulatory cells? Immunity 2001;14(4):399-406.
45. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002;195(12):1641-1646.
46. + T cell-mediated graft rejection: Implications for anti-CD154 immunotherapy. J Immunol 2002;169(10):5401-5404.
47. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
48. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: The tolerogenic function of immature dendritic cells. Immunol Cell Biol 2002;80(5):477-483.
49. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27(12):3135-3142.
50. Sparwasser T, Vabulas RM, Villmow B, Lipford GB, Wagner H. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur J Immunol 2000;30(12):3591-3597.
51. Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, Ellwart JW, et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998;28(6):2045-2054.
52. Lapointe R, Toso JF, Butts C, Young HA, Hwu P. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur J Immunol 2000;30(11):3291-3298.
53. De Smedt T, Pajak B, Klaus GG, Noelle RJ, Urbain J, Leo O, et al. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol 1998;161(9):4476-4479.
54. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogenic immature human dendritic cells. J Exp Med 2000;192(9):1213-1222.
55. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001;193(2):233-238.
56. + regulatory T cells by targeting of antigens to immature dendritic cells, Blood (2003) prepublished online January 23.
57. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001;22(7):394-400.
58. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk A H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997;159(10):4772-4780.
59. Steinbrink K, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 1999;93(5):1634-1642.
60. Morelli AE, Hackstein H, Thomson AW. Potential of tolerogenic dendritic cells for transplantation. Semin Immunol 2001;13(5):323-335.
61. Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002;99(7):2468-2476.
62. Lutz MB, Suri RM, Niimi M, Ogilvie AL, Kukutsch NA, Rossner S, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000;30(7):1813-1822.
63. + T cell tolerance. J Exp Med 2002;196(12):1627-1638.
64. Figdor CG, Van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002;2(2):77-84.
65. Hartgers FC, Figdor CG, Adema GJ. Towards a molecular understanding of dendritic cell immunobiology. Immunol Today 2000;21(11):542-545.